NOVATIS AG
Patent Applications and Registrations
Patent applications and USPTO patent grants for NOVATIS AG.The latest application filed is for "combination of somatostatin-analogs with 11beta-hydroxylase inhibitors".
- NOVATIS AG - Basel CH
- Novatis AG -
| Patent | Date |
|---|---|
| Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Grant 9,340,537 - Furet , et al. May 17, 2 | 2016-05-17 |
| Combination Of Somatostatin-analogs With 11beta-hydroxylase Inhibitors App 20150087588 - Gericke; Germo Hans ; et al. | 2015-03-26 |
| RNAi Inhibition of Alpha-ENaC Expression App 20100190714 - VAN HEEKE; Gino ; et al. | 2010-07-29 |
| Method for applying a coating Grant 6,811,805 - Gilliard , et al. November 2, 2 | 2004-11-02 |
| Epothilone derivatives and their use as antitumor agents Grant 6,387,927 - Altmann , et al. May 14, 2 | 2002-05-14 |
| Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis Grant 6,204,243 - Posanski March 20, 2 | 2001-03-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 